Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 203

1.

Ambulatory blood pressure and arterial stiffness web-based telemonitoring in patients at cardiovascular risk. First results of the VASOTENS (Vascular health ASsessment Of The hypertENSive patients) Registry.

Omboni S, Posokhov I, Parati G, Rogoza A, Kotovskaya Y, Arystan A, Avolio A, Barkan V, Bulanova N, Cardona Muñoz E, Grigoricheva E, Konradi A, Minyukhina I, Muiesan ML, Mulè G, Orlova I, Pereira T, Peixoto Maldonado JM, Statsenko ME, Tilea I, Waisman G; VASOTENS Registry Study Group.

J Clin Hypertens (Greenwich). 2019 Jul 11. doi: 10.1111/jch.13623. [Epub ahead of print]

2.

Connected Health in Hypertension Management.

Omboni S.

Front Cardiovasc Med. 2019 Jun 13;6:76. doi: 10.3389/fcvm.2019.00076. eCollection 2019. Review.

3.

Telemonitoring of 24-Hour Blood Pressure in Local Pharmacies and Blood Pressure Control in the Community: The Templar Project.

Omboni S, Mancinelli A, Rizzi F, Parati G; TEMPLAR (TEleMonitoring of blood Pressure in Local phARmacies) Project Group.

Am J Hypertens. 2019 Jun 11;32(7):629-639. doi: 10.1093/ajh/hpz049.

PMID:
30976783
4.

Angiotensin Receptor Blockers Versus Angiotensin Converting Enzyme Inhibitors for the Treatment of Arterial Hypertension and the Role of Olmesartan.

Omboni S, Volpe M.

Adv Ther. 2019 Feb;36(2):278-297. doi: 10.1007/s12325-018-0859-x. Epub 2018 Dec 27. Review.

PMID:
30591990
5.

MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol.

Parati G, Agabiti-Rosei E, Bakris GL, Bilo G, Branzi G, Cecchi F, Chrostowska M, De la Sierra A, Domenech M, Dorobantu M, Faria T, Huo Y, Jelaković B, Kahan T, Konradi A, Laurent S, Li N, Madan K, Mancia G, McManus RJ, Modesti PA, Ochoa JE, Octavio JA, Omboni S, Palatini P, Park JB, Pellegrini D, Perl S, Podoleanu C, Pucci G, Redon J, Renna N, Rhee MY, Rodilla Sala E, Sanchez R, Schmieder R, Soranna D, Stergiou G, Stojanovic M, Tsioufis K, Valsecchi MG, Veglio F, Waisman GD, Wang JG, Wijnmaalen P, Zambon A, Zanchetti A, Zhang Y.

BMJ Open. 2018 Dec 19;8(12):e021038. doi: 10.1136/bmjopen-2017-021038.

6.

Pharmacist-led hypertension management combined with blood pressure telemonitoring in a primary care setting may be cost-effective in high-risk patients.

Omboni S.

J Clin Hypertens (Greenwich). 2019 Feb;21(2):169-172. doi: 10.1111/jch.13467. Epub 2018 Dec 20. No abstract available.

7.

Physician-pharmacist collaborative practice and telehealth may transform hypertension management.

Omboni S, Tenti M, Coronetti C.

J Hum Hypertens. 2019 Mar;33(3):177-187. doi: 10.1038/s41371-018-0147-x. Epub 2018 Dec 13. Review.

PMID:
30546052
8.

Simultaneous double arm automated blood pressure measurement for the screening of subjects with potential vascular disease: a community study.

Omboni S, Verberk WJ.

Blood Press. 2019 Feb;28(1):15-22. doi: 10.1080/08037051.2018.1539619. Epub 2018 Nov 21.

PMID:
30460865
9.

Efficacy of Zofenopril Alone or in Combination with Hydrochlorothiazide in Patients with Kidney Dysfunction.

Omboni S, Borghi C.

Curr Clin Pharmacol. 2019;14(1):5-15. doi: 10.2174/1574884713666181025145404.

PMID:
30360726
10.

Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan.

Omboni S, Volpe M.

Cardiovasc Ther. 2018 Dec;36(6):e12471. doi: 10.1111/1755-5922.12471. Epub 2018 Nov 13. Review.

11.

Effects on 24-hour blood pressure variability of ace-inhibition and calcium channel blockade as monotherapy or in combination.

Parati G, Castiglioni P, Omboni S, Faini A.

Sci Rep. 2018 Sep 13;8(1):13779. doi: 10.1038/s41598-018-31746-2.

12.

Telepharmacy for the management of cardiovascular patients in the community.

Omboni S, Tenti M.

Trends Cardiovasc Med. 2019 Feb;29(2):109-117. doi: 10.1016/j.tcm.2018.07.002. Epub 2018 Jul 12. Review.

PMID:
30037524
13.

Efficacy of zofenopril in combination with thiazide diuretics in patients with acute myocardial infarction: a pooled individual data analysis of four randomized, double-blind, controlled, prospective studies.

Borghi C, Omboni S, Reggiardo G, Bacchelli S, Esposti DD, Ambrosioni E.

Ther Clin Risk Manag. 2018 Jul 9;14:1185-1190. doi: 10.2147/TCRM.S165629. eCollection 2018.

14.

A working definition of white-coat hypertension must include nocturnal blood pressure.

Omboni S.

J Clin Hypertens (Greenwich). 2018 Jul 15. doi: 10.1111/jch.13355. [Epub ahead of print] No abstract available.

15.

Home blood pressure telemonitoring in the 21st century.

Parati G, Dolan E, McManus RJ, Omboni S.

J Clin Hypertens (Greenwich). 2018 Jul;20(7):1128-1132. doi: 10.1111/jch.13305.

16.

Efficacy of zofenopril in combination with amlodipine in patients with acute myocardial infarction: a pooled individual patient data analysis of four randomized, double-blind, controlled, prospective studies.

Borghi C, Omboni S, Reggiardo G, Bacchelli S, Degli Esposti D, Ambrosioni E; SMILE (Survival of Myocardial Infarction Long-Term Evaluation) Working Project.

Curr Med Res Opin. 2018 Oct;34(10):1869-1874. doi: 10.1080/03007995.2018.1496076. Epub 2018 Jul 31.

PMID:
29972310
17.

Has the time come for self-management of blood pressure and antihypertensive medications by patients?

Omboni S.

J Hypertens. 2018 Aug;36(8):1654-1655. doi: 10.1097/HJH.0000000000001797. No abstract available.

PMID:
29952851
18.

Effects of the concomitant administration of xanthine oxidase inhibitors with zofenopril or other ACE-inhibitors in post-myocardial infarction patients: a meta-analysis of individual data of four randomized, double-blind, prospective studies.

Borghi C, Omboni S, Reggiardo G, Bacchelli S, Esposti DD, Ambrosioni E; SMILE Working Project.

BMC Cardiovasc Disord. 2018 Jun 5;18(1):112. doi: 10.1186/s12872-018-0800-x.

19.

Efficacy and Safety of Zofenopril Versus Ramipril in the Treatment of Myocardial Infarction and Heart Failure: A Review of the Published and Unpublished Data of the Randomized Double-Blind SMILE-4 Study.

Borghi C, Omboni S, Novo S, Vinereanu D, Ambrosio G, Ambrosioni E.

Adv Ther. 2018 May;35(5):604-618. doi: 10.1007/s12325-018-0697-x. Epub 2018 Apr 17. Review.

20.

Effectiveness of pharmacist's intervention in the management of cardiovascular diseases.

Omboni S, Caserini M.

Open Heart. 2018 Jan 3;5(1):e000687. doi: 10.1136/openhrt-2017-000687. eCollection 2018. Review.

22.

Masked Uncontrolled Hypertension in the Elderly: A Dangerous Affair.

Omboni S.

Am J Hypertens. 2017 Nov 1;30(11):1066-1068. doi: 10.1093/ajh/hpx136. No abstract available.

PMID:
28985285
23.

Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis.

Tucker KL, Sheppard JP, Stevens R, Bosworth HB, Bove A, Bray EP, Earle K, George J, Godwin M, Green BB, Hebert P, Hobbs FDR, Kantola I, Kerry SM, Leiva A, Magid DJ, Mant J, Margolis KL, McKinstry B, McLaughlin MA, Omboni S, Ogedegbe O, Parati G, Qamar N, Tabaei BP, Varis J, Verberk WJ, Wakefield BJ, McManus RJ.

PLoS Med. 2017 Sep 19;14(9):e1002389. doi: 10.1371/journal.pmed.1002389. eCollection 2017 Sep. Review.

24.

Accuracy of Cuff-Measured Blood Pressure: Systematic Reviews and Meta-Analyses.

Picone DS, Schultz MG, Otahal P, Aakhus S, Al-Jumaily AM, Black JA, Bos WJ, Chambers JB, Chen CH, Cheng HM, Cremer A, Davies JE, Dwyer N, Gould BA, Hughes AD, Lacy PS, Laugesen E, Liang F, Melamed R, Muecke S, Ohte N, Okada S, Omboni S, Ott C, Peng X, Pereira T, Pucci G, Rajani R, Roberts-Thomson P, Rossen NB, Sueta D, Sinha MD, Schmieder RE, Smulyan H, Srikanth VK, Stewart R, Stouffer GA, Takazawa K, Wang J, Westerhof BE, Weber F, Weber T, Williams B, Yamada H, Yamamoto E, Sharman JE.

J Am Coll Cardiol. 2017 Aug 1;70(5):572-586. doi: 10.1016/j.jacc.2017.05.064. Review.

25.

Smartphone Applications for Hypertension Management: a Potential Game-Changer That Needs More Control.

Parati G, Torlasco C, Omboni S, Pellegrini D.

Curr Hypertens Rep. 2017 Jun;19(6):48. doi: 10.1007/s11906-017-0743-0. Review.

PMID:
28501982
26.

Erratum to: Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.

Omboni S, Malacco E, Napoli C, Modesti PA, Manolis A, Parati G, Agabiti-Rosei E, Borghi C.

Adv Ther. 2017 Jun;34(6):1498-1499. doi: 10.1007/s12325-017-0537-4. No abstract available.

27.

Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.

Omboni S, Malacco E, Napoli C, Modesti PA, Manolis A, Parati G, Agabiti-Rosei E, Borghi C.

Adv Ther. 2017 Apr;34(4):784-798. doi: 10.1007/s12325-017-0497-8. Epub 2017 Mar 4. Review. Erratum in: Adv Ther. 2017 Jun;34(6):1498-1499.

28.
29.

Cardioprotective role of zofenopril in hypertensive patients with acute myocardial infarction: a pooled individual data analysis of the SMILE studies.

Borghi C, Omboni S, Reggiardo G, Bacchelli S, Degli Esposti D, Ambrosioni E; : on behalf of the SMILE (Survival of Myocardial Infarction Long-term Evaluation) Working Project.

Blood Press. 2017 Aug;26(4):211-219. doi: 10.1080/08037051.2017.1281712. Epub 2017 Feb 3.

PMID:
28155333
30.

Relationships between 24-h blood pressure variability and 24-h central arterial pressure, pulse wave velocity and augmentation index in hypertensive patients.

Omboni S, Posokhov IN, Rogoza AN.

Hypertens Res. 2017 Apr;40(4):385-391. doi: 10.1038/hr.2016.156. Epub 2016 Nov 24.

PMID:
27881851
32.

Zofenopril and ramipril in patients with left ventricular systolic dysfunction after acute myocardial infarction: A propensity analysis of the Survival of Myocardial Infarction Long-term Evaluation (SMILE) 4 study.

Borghi C, Omboni S, Novo S, Vinereanu D, Ambrosio G, Ambrosioni E; SMILE-4 Working Party.

J Renin Angiotensin Aldosterone Syst. 2016 Oct 5;17(4). pii: 1470320316656480. Print 2016 Oct.

33.

Twenty-Four-Hour Ambulatory Pulse Wave Analysis in Hypertension Management: Current Evidence and Perspectives.

Omboni S, Posokhov IN, Kotovskaya YV, Protogerou AD, Blacher J.

Curr Hypertens Rep. 2016 Oct;18(10):72. doi: 10.1007/s11906-016-0681-2. Review.

PMID:
27659178
34.
35.

Hypertension types defined by clinic and ambulatory blood pressure in 14 143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study.

Omboni S, Aristizabal D, De la Sierra A, Dolan E, Head G, Kahan T, Kantola I, Kario K, Kawecka-Jaszcz K, Malan L, Narkiewicz K, Octavio JA, Ohkubo T, Palatini P, Siègelovà J, Silva E, Stergiou G, Zhang Y, Mancia G, Parati G; ARTEMIS (international Ambulatory blood pressure Registry: TEleMonitoring of hypertension and cardiovascular rISk project) Investigators.

J Hypertens. 2016 Nov;34(11):2187-98. doi: 10.1097/HJH.0000000000001074.

PMID:
27512964
36.

Do arterial stiffness and wave reflections improve more with angiotensin receptor blockers than with other antihypertensive drug classes?

Omboni S.

J Thorac Dis. 2016 Jul;8(7):1417-20. doi: 10.21037/jtd.2016.05.32. No abstract available.

37.

Vascular Health Assessment of The Hypertensive Patients (VASOTENS) Registry: Study Protocol of an International, Web-Based Telemonitoring Registry for Ambulatory Blood Pressure and Arterial Stiffness.

Omboni S, Posokhov IN, Parati G, Avolio A, Rogoza AN, Kotovskaya YV, Mulè G, Muiesan ML, Orlova IA, Grigoricheva EA, Cardona Muñoz E, Zelveian PH, Pereira T, Peixoto Maldonado JM.

JMIR Res Protoc. 2016 Jun 29;5(2):e137. doi: 10.2196/resprot.5619.

38.

Methodology and technology for peripheral and central blood pressure and blood pressure variability measurement: current status and future directions - Position statement of the European Society of Hypertension Working Group on blood pressure monitoring and cardiovascular variability.

Stergiou GS, Parati G, Vlachopoulos C, Achimastos A, Andreadis E, Asmar R, Avolio A, Benetos A, Bilo G, Boubouchairopoulou N, Boutouyrie P, Castiglioni P, de la Sierra A, Dolan E, Head G, Imai Y, Kario K, Kollias A, Kotsis V, Manios E, McManus R, Mengden T, Mihailidou A, Myers M, Niiranen T, Ochoa JE, Ohkubo T, Omboni S, Padfield P, Palatini P, Papaioannou T, Protogerou A, Redon J, Verdecchia P, Wang J, Zanchetti A, Mancia G, O'Brien E.

J Hypertens. 2016 Sep;34(9):1665-77. doi: 10.1097/HJH.0000000000000969.

PMID:
27214089
39.

Opportunistic screening of atrial fibrillation by automatic blood pressure measurement in the community.

Omboni S, Verberk WJ.

BMJ Open. 2016 Apr 12;6(4):e010745. doi: 10.1136/bmjopen-2015-010745.

40.

Telemedicine and M-Health in Hypertension Management: Technologies, Applications and Clinical Evidence.

Omboni S, Caserini M, Coronetti C.

High Blood Press Cardiovasc Prev. 2016 Sep;23(3):187-96. doi: 10.1007/s40292-016-0143-6. Epub 2016 Apr 12. Review.

PMID:
27072129
41.

Zofenopril and Ramipril in Combination with Acetyl Salicylic Acid in Postmyocardial Infarction Patients with Left Ventricular Systolic Dysfunction: A Retrospective Analysis of the SMILE-4 Randomized, Double-Blind Study in Diabetic Patients.

Borghi C, Omboni S, Novo S, Vinereanu D, Ambrosio G, Ambrosioni E; SMILE-4 Working Party.

Cardiovasc Ther. 2016 Apr;34(2):76-84. doi: 10.1111/1755-5922.12175.

PMID:
26789425
42.

Erratum to: Early (≤1-h) vs. late (>1-h) administration of frovatriptan plus dexketoprofen combination vs. frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel group study.

Allais G, Bussone G, Tullo V, Cortelli P, Valguarnera F, Barbanti P, Sette G, Frediani F, D'Arrigo G, d'Onofrio F, Comi G, Curone M, Colombo B, Omboni S, Benedetto C.

Neurol Sci. 2016 Feb;37(2):331. doi: 10.1007/s10072-015-2445-1. No abstract available.

PMID:
26705251
43.

Zofenopril or irbesartan plus hydrochlorothiazide in elderly patients with isolated systolic hypertension untreated or uncontrolled by previous treatment: a double-blind, randomized study.

Modesti PA, Omboni S, Taddei S, Ghione S, Portaluppi F, Pozzilli P, Volpe M, Arca M, Calabrò P, Fulgheri PL, Bucci M, Berra S, Villani GQ, Vladoianu M, Popescu E, Velican VG, Pirvu O.

J Hypertens. 2016 Mar;34(3):576-87; discussion 587. doi: 10.1097/HJH.0000000000000805.

PMID:
26703917
44.

Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database.

Mancia G, Omboni S, Chazova I, Coca A, Girerd X, Haller H, Parati G, Pauletto P, Pupek-Musialik D, Svyshchenko Y; FELT Study Group.

J Hypertens. 2016 Jan;34(1):139-48. doi: 10.1097/HJH.0000000000000767.

PMID:
26630216
45.

Screening for atrial fibrillation with automated blood pressure measurement: Research evidence and practice recommendations.

Verberk WJ, Omboni S, Kollias A, Stergiou GS.

Int J Cardiol. 2016 Jan 15;203:465-73. doi: 10.1016/j.ijcard.2015.10.182. Epub 2015 Oct 26. Review.

47.

Cardioprotective role of zofenopril in patients with acute myocardial infarction: a pooled individual data analysis of four randomised, double-blind, controlled, prospective studies.

Borghi C, Omboni S, Reggiardo G, Bacchelli S, Degli Esposti D, Ambrosioni E.

Open Heart. 2015 Sep 8;2(1):e000220. doi: 10.1136/openhrt-2014-000220. eCollection 2015.

48.

Individual patient data meta-analysis of self-monitoring of blood pressure (BP-SMART): a protocol.

Tucker KL, Sheppard JP, Stevens R, Bosworth HB, Bove A, Bray EP, Godwin M, Green B, Hebert P, Hobbs FD, Kantola I, Kerry S, Magid DJ, Mant J, Margolis KL, McKinstry B, Omboni S, Ogedegbe O, Parati G, Qamar N, Varis J, Verberk W, Wakefield BJ, McManus RJ.

BMJ Open. 2015 Sep 15;5(9):e008532. doi: 10.1136/bmjopen-2015-008532. Erratum in: BMJ Open. 2016 May 17;6(5):e008532corr1.

50.

Ethnic differences in the degree of morning blood pressure surge and in its determinants between Japanese and European hypertensive subjects: data from the ARTEMIS study.

Hoshide S, Kario K, de la Sierra A, Bilo G, Schillaci G, Banegas JR, Gorostidi M, Segura J, Lombardi C, Omboni S, Ruilope L, Mancia G, Parati G.

Hypertension. 2015 Oct;66(4):750-6. doi: 10.1161/HYPERTENSIONAHA.115.05958. Epub 2015 Aug 24.

PMID:
26303289

Supplemental Content

Loading ...
Support Center